BISACODYL DELAYED-RELEASE TABLETS

The Defense Logistics Agency awarded a delivery order under the IDIQ contract SPE2DX25D9900 to DMS PHARMACEUTICAL GROUP INC, identified by CAGE code 1UNB0, for the supply of one batch of BISACODYL DELAYED-RELEASE TABLETS, identified by NSN 6505001182759 and NDC 00904-6407-61. The total value of this specific delivery order is $1.08, issued on July 15, 2026, with delivery scheduled for July 30, 2026, to Fort Campbell, Kentucky, under FOB Destination terms. The contract is classified as a commercial item acquisition governed by FAR 52.212-4 and related commercial clauses, incorporating standard requirements on trafficking in persons, offeror certifications, and contract terms. The awardee is certified as a Women-Owned Small Business, affirming socioeconomic status under FAR 19.15, and is subject to compliance and possible post-award verification for this designation. Packaging and marking instructions require traceable freight shipping with no parcel post, and all shipments must be labeled with the CAGE code 1LEZO, NDC, and TCN W34GMT61950179, though no specific MIL-STD packaging or preservation standards are cited. Inspection and acceptance occur at the destination by an authorized government representative, with confirmation based solely on conformity to contract terms. Invoicing must follow DFARS 252.232-7003, mandating electronic submission via WAWF, and payments will be processed by the Defense Finance and Accounting Service in Columbus, Ohio. Contract administration is managed by Lorenda Ferraiolo as the contracting officer, with oversight support from Catherine Gilbert and Shairy M. Cartagena at DLA Troop Support in Philadelphia. The contract references no option periods, special security requirements, OCI provisions, or unique performance specifications beyond the prescribed product and delivery conditions, and the underlying basic contract has a $20 million ceiling that is not being utilized by this minimal-order transaction.